drugset / Trial / NCT01086865

Clinical Study Phase III, Randomized, Double-blind, Prospective and Comparative to Evaluate the Efficacy and Tolerability of Using APETIVITON BC Compared to Petivit BC in Appetite Stimulate.

NCT01086865 ↗

Phase 3 Unknown 150 enrolled Cifarma Cientifica Farmaceutica Ltda
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical study phase III, randomized, double-blind, prospective, comparative non-inferiority to evaluate the efficacy and tolerability of using APETIVITON BC compared to Petivit BC in appetite stimulate in children, adults and elderly.

Timeline

Start
2010-08
Primary completion
2010-11
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Apetiviton BC Unknown 2.5 ml —
Subject Apetiviton BC Unknown 5 ml —

Indications

No indication recorded.